Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

A visible-light-promoted perfluoroalkylation/cyclization cascade towards perfluoroalkyl-substituted iminoisobenzofurans using the EDA complex

Zilin Liu , Shuo Gao, Mingxi Hu, Zhen-Hua Zhang*, Pifeng Wei* and Mengmeng Zhao*
School of Chemistry and Chemical Engineering, Linyi University, Linyi 276000, P. R. China. E-mail: zhangzhenhua@iccas.ac.cn; weipifeng@lyu.edu.cn; zhaomengmeng@lyu.edu.cn

Received 28th May 2025 , Accepted 28th July 2025

First published on 29th July 2025


Abstract

Perfluoroalkyl-functionalized heterocycles exhibit profoundly modified bioactivities, motivating the development of efficient methods for precise perfluoroalkyl group installation. A new metal-free photoinduced radical-initiated cascade reaction was developed for the rapid synthesis of perfluoroalkyl-substituted iminoisobenzofurans by reacting various perfluoroalkyl iodides (RF-I) under mild reaction conditions. In this reaction system, the formation of electron donor–acceptor (EDA) complexes is pivotal for the visible-light promoted transformation in the absence of additional photocatalytic species.


Introduction

Fluoroalkylated scaffolds are pivotal structures in pharmaceuticals and materials science, as they can significantly alter the physical and chemical properties of molecules, such as enhancing lipophilicity, bioavailability and metabolic stability, making them indispensable in drug design and material development.1 Consequently, the exploration of new ways to incorporate fluoroalkyl groups into organic molecules has become a major topic in chemical research.2 While research efforts have predominantly focused on difluoromethyl and trifluoromethyl group incorporation, significant progress has also been made in longer-chain perfluoroalkylation (CnF2n+1, n ≥ 2) through various approaches including electron donor–acceptor (EDA) complex-mediated methodologies.3 However, challenges remain in developing general and practical methods that accommodate diverse substrates under mild reaction conditions. As pivotal feedstocks in the chemical industry, radical-initiated fluoroalkylation of unsaturated C[double bond, length as m-dash]C bonds in alkenes has emerged as a privileged synthetic strategy for accessing fluorinated compounds.4,5 Over the past decade, alkene-based tandem fluoroalkylation/cyclization reactions have attracted substantial research attention in synthetic chemistry owing to their exceptional efficiency in constructing fluoroalkyl-substituted carbocyclic and heterocyclic motifs.6,7 Mechanistically, these transformations involve the generation of reactive fluoroalkyl radical intermediates from diverse fluoroalkyl precursors under transition-metal catalysis, thermal activation, photoredox catalysis, or electrochemical conditions. These fluoroalkyl radicals subsequently undergo regioselective addition to the alkene π-system, followed by an intramolecular cascade cyclization reaction with tethered nucleophiles to form cyclic molecules bearing fluoroalkyl substituents (Scheme 1a). Fluoroalkyl iodides serve as readily available and economical precursors for generating fluoroalkyl radicals that efficiently undergo addition to alkene C[double bond, length as m-dash]C bonds, establishing a fundamental platform for developing diverse synthetic methodologies.8
image file: d5ob00888c-s1.tif
Scheme 1 Strategies for synthesizing perfluoroalkyl-substituted iminoisobenzofurans.

The isobenzofuran motif serves as a key structural feature in numerous natural products and bioactive molecules.9 Given its significance, researchers have developed various efficient strategies for constructing this scaffold. Among these derivatives, iminoisobenzofurans have gained increasing attention from synthetic chemists in recent years as particularly pivotal structures.10 Notably, radical-mediated tandem addition/cyclization strategies have emerged as innovative approaches for constructing functionalized iminoisobenzofurans from ortho-vinyl amides (Scheme 1b).11 Representative transformations in this domain include (a) K2S2O8-promoted thiocyano cyclization, (b) electrochemical oxidative seleno/thio-cyclization, and (c) visible-light-induced sulfonamidylative cyclization. While methods for incorporating fluoroalkyl groups into iminoisobenzofuran frameworks remain limited, significant progress has been made in recent years (Scheme 1c). In 2018, the Xiao group pioneered a visible-light mediated photocatalytic radical addition/cyclization reaction between o-vinyl-N-alkoxybenzamides and Umemoto's reagent.12 Building upon this work, we recently reported a copper-catalyzed radical addition/cyclization cascade of o-alkenyl-N-alkylbenzamides with Togni's reagent, which provides complementary access to diverse CF3-containing iminoisobenzofuran analogs.13

Visible-light-induced reactions via EDA complexes in the absence of organic and metal photocatalysts have emerged as an increasingly important research focus since 2000.14 In these studies, perfluoroalkyl iodides assemble into EDA complexes with electron-rich species through electrostatic stabilization. Photoexcitation of these complexes induces intramolecular electron transfer from heteroatom lone pairs to the C–I σ* antibonding orbital of RF-I, thereby generating reactive perfluoroalkyl radicals.15 This innovative strategy eliminates the need for exogenous photocatalysts while maintaining exceptional selectivity under visible-light irradiation, representing a significant advancement in sustainable synthetic methodologies. For instance, Yu achieved efficient synthesis of perfluoroalkyl-substituted benzimidazo[2,1-a]isoquinolin-6(5H)-ones and indolo[2,1-a]isoquinolin-6(5H)-ones through a visible-light-induced tandem radical addition/cyclization strategy, using an EDA complex formed between perfluoroalkyl iodides and N,N,N′,N′-tetramethylethane-1,2-diamine (TMEDA).16 Building upon a similar strategy, Yang et al. established a photocatalytic protocol involving a radical perfluoroalkylation/cyclization cascade to construct polycyclic quinazolinones containing perfluoroalkyl groups from N-cyanamide alkenes and perfluoroalkyl iodides.17 Inspired by these elegant precedents, we herein report a radical cascade addition/cyclization reaction of o-alkenylbenzamides using an EDA complex under visible-light irradiation for constructing perfluoroalkylated iminoisobenzofuran derivatives (Scheme 1d).

Results and discussion

We initially chose o-alkenylbenzamide 1a as a model substrate and C4F9I 2a as the perfluoroalkyl radical precursor under visible-light irradiation to investigate the cyclization (Table 1). We found that in the presence of N,N,N′,N′-tetramethylethane-1,2-diamine (TMEDA) under 420–430 nm LED irradiation for 12 h, this reaction proceeded in MeCN to generate the C4F9-substituted iminoisobenzofuran 3a in 81% yield (entry 1). Further optimization using different organic bases, including Et3N, DBU, DABCO, and Cs2CO3, demonstrated that other bases were less effective (entries 2–5). We then examined the effect of irradiation wavelength on the reaction using LEDs with different wavelengths. Notably, the reaction maintained a comparable yield when a 380–390 nm LED was employed. However, a significant yield reduction to 56% was observed when a broader-spectrum 400–800 nm LED was used, and the yield showed a marked decline at longer wavelengths (entries 6–8). Substituting the solvent MeCN with THF, DCE, DMSO, 1,4-dioxane or methanol failed to significantly enhance the reaction yield (entries 9–13). When the amount of TMEDA was reduced to 0.2 mmol, the yield decreased to 53% (entry 14). Finally, the control experiments confirmed that both light irradiation and TMEDA were essential for this perfluoroalkylation/cyclization (entries 15 and 16).
Table 1 Optimization of reaction conditionsa

image file: d5ob00888c-u1.tif

Entry Base LED Solvent Yieldb (%)
a Reaction conditions: 1a (0.2 mmol), 2a (0.4 mmol), base (0.4 mmol), in dry solvent (2.0 mL) under N2 at room temperature with LED irradiation for 12 h.b Isolated yield based on 1a.c TMEDA (0.2 mmol) was added. DABCO, 1,4-diazocyclic [2.2.2] octane; DBU, 8-diazabicyclo [5.4.0] undec-7-ene; THF, tetrahydrofuran; DCE, dichloroethane; and DMSO, dimethyl sulfoxide.
1 TMEDA 420–430 nm MeCN 81
2 Et3N 420–430 nm MeCN 42
3 DBU 420–430 nm MeCN 65
4 DABCO 420–430 nm MeCN 75
5 Cs2CO3 420–430 nm MeCN 28
6 TMEDA 380–390 nm MeCN 79
7 TMEDA 520–530 nm MeCN Trace
8 TMEDA 400–800 nm MeCN 56
9 TMEDA 420–430 nm THF 35
10 TMEDA 420–430 nm DCE 45
11 TMEDA 420–430 nm DMSO 53
12 TMEDA 420–430 nm 1,4-Dioxane 20
13 TMEDA 420–430 nm MeOH 41
14c TMEDA 420–430 nm MeCN 53
15 420–430 nm MeCN 0
16 TMEDA Dark MeCN 0


Upon establishing the optimal reaction conditions, we subsequently examined the substrate generality of the photoinduced perfluoroalkylation/cyclization tandem process with various o-alkenyl amide derivatives (Scheme 2). Initially, a broad range of amides bearing diverse alkyl (tert-butyl, n-butyl, n-hexyl, and isopropyl) and cycloalkyl (cyclopentyl and cyclohexyl) substituents all underwent the desired transformation with good to excellent yields (3b–3g). Notably, the N-benzylamide substrate showed enhanced reactivity, providing the target product 3h in a higher yield (83%). Furthermore, the reaction exhibited excellent functional group tolerance towards various N-benzyl-substituted amides, with electron-donating (methyl and methoxy) and electron-withdrawing (bromo, chloro, and cyano) substituents on the phenyl ring all proving compatible, yielding products 3i–3o in 66–85% yields. Next, when the benzene ring was replaced with furan or thiophene heterocycles, the corresponding perfluoroalkylated iminoisobenzofurans 3p and 3q were obtained in 72% and 75% yields, respectively. Also, substrates bearing chloro or bromo substituents at different positions on the benzene ring connected to the amide group also afforded the desired products 3r–3u in 67–79% yields. However, the tandem reaction efficiency significantly decreased when the benzene ring was replaced with a thiophene moiety (3v, 21%). The conversion yield decreased significantly when the alkyl group in the substrate was replaced with an alkoxy group (3w, 60%). Finally, when o-alkenyl-substituted benzoic acid was used as the substrate, the C4F9-containing isobenzofuran product 3x was obtained in 44% yield.


image file: d5ob00888c-s2.tif
Scheme 2 Substrate scope of amides. Reaction conditions: 1 (0.2 mmol), 2a (0.4 mmol), TMEDA (0.4 mmol), in dry MeCN (2.0 mL) under N2 at room temperature with 420–430 nm LED irradiation for 12 h. Isolated yield. a[thin space (1/6-em)]o-Alkenylbenzoic acid was used.

Following the evaluation of the substrate scope with o-alkenyl amides, we further investigated the reactivity of diverse perfluoroalkyl radical precursors in the cyclization reaction under optimized conditions (Scheme 3). Systematic screening of commercially available perfluoroalkyl iodides (IC3F7, IC6F13, IC8F17, IC10F21, and ICF(CF3)2) revealed that all derivatives could effectively participate in the transformation, consistently delivering perfluoroalkyl-substituted iminoisobenzofurans (4a–4e) in excellent yields (69–80%). Encouraged by these results, we subsequently examined the reactivity of trifluoroiodomethane (CF3I) and ethyl difluoroiodoacetate (ICF2COOEt) with o-alkenylbenzamide substrates. Remarkably, employing CF3I as the trifluoromethylation reagent under the standard conditions afforded the corresponding trifluoromethylated products 4f and 4g in 77% and 63% yields, respectively, demonstrating the versatility of this radical cascade process. Finally, the reaction with ICF2COOEt as the radical precursor was performed under standard conditions, which successfully afforded the difluoroalkylated product 4h with good compatibility.


image file: d5ob00888c-s3.tif
Scheme 3 Substrate scope of perfluoroalkyl iodides. Reaction conditions: 1a (0.2 mmol), 2 (0.4 mmol), TMEDA (0.4 mmol), in dry MeCN (2.0 mL) under N2 at room temperature with 420–430 nm LED irradiation for 12 h. Isolated yield. a[thin space (1/6-em)] 25 wt% CF3I solution in THF was used. b[thin space (1/6-em)]N-Propargyl-substituted amide was used.

To further elucidate the reaction mechanism of the visible-light-promoted perfluoroalkylation/cyclization, we conducted several control experiments. Initially, when 3.0 equivalents of either 2,6-di-tert-butyl-4-methylphenol (BHT) or 2,2,6,6-tetramethylpiperidin-1-oxyl (TEMPO) were introduced under standard reaction conditions, the process was completely suppressed (Scheme 4a). The corresponding free radical adduct 5a was also identified by HRMS and 19F NMR, and these findings strongly suggested the crucial role of radical intermediates in this transformation. Scheme 4b displays the UV-vis absorption spectral changes of C4F9I (0.1 M), TMEDA (0.1 M), and their mixture in acetonitrile solution. Upon mixing the two components, the solution color gradually changed from colorless to yellow, accompanied by a distinct bathochromic shift in the absorption spectrum. In addition, Job's plot analysis showed that the EDA complex was composed of C4F9I and TMEDA in a 1[thin space (1/6-em)]:[thin space (1/6-em)]1 ratio (Scheme 4c). The measured quantum yield (Φ) of 0.46 (see the SI) suggested that the reaction may not proceed through a highly efficient radical chain process, although the possibility of chain propagation cannot be completely excluded, given potential inefficiencies in the initiation step.


image file: d5ob00888c-s4.tif
Scheme 4 Investigation of the reaction mechanism.

Based on the aforementioned mechanistic studies and previous literature,15–17 a plausible reaction mechanism is illustrated in Scheme 5. Initially, TMEDA formed an EDA complex with C4F9I, which underwent dissociation under blue light irradiation to generate the C4F9 radical, radical cation A, and iodide ion. Subsequently, the C4F9 radical attacked the C[double bond, length as m-dash]C bond of amide 1a, forming the radical intermediate B. This key intermediate then underwent two possible pathways to form the benzylic carbocation C: (a) direct oxidation via SET with TMEDA radical cation A (path I) or (b) regeneration of the perfluoroalkyl radical and iodide anion through a SET mechanism in the presence of 2a (path II). Ultimately, the desired product 3a was formed through intramolecular nucleophilic attack, followed by deprotonation.


image file: d5ob00888c-s5.tif
Scheme 5 Possible reaction pathway.

Conclusions

In conclusion, we have developed a novel and efficient visible-light-induced radical cyclization for the synthesis of perfluoroalkyl-substituted iminoisobenzofuran derivatives. This transformation employs commercially available perfluoroalkyl iodides and o-alkenyl benzamides as starting materials, where the iodides serve as radical precursors through the formation of EDA complexes with TMEDA under photoirradiation conditions. This one-pot protocol offers significant advantages including operational simplicity under mild conditions, photocatalyst-free conditions that eliminate the need for expensive and potentially toxic transition metal complexes, and excellent functional group tolerance with broad substrate scope. These distinctive features make this methodology particularly attractive for the construction of valuable fluorinated heterocycles with potential bioactivity.

Author contributions

Zilin Liu: investigation, data curation, and methodology. Shuo Gao: investigation and data curation. Mingxi Hu: data curation. Zhen-Hua Zhang: writing – review & editing, supervision, funding acquisition, and conceptualization. Pifeng Wei: writing – original draft. Mengmeng Zhao: supervision and writing – review & editing.

Conflicts of interest

There are no conflicts to declare.

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

The Supplementary Information file contains experimental details, characterization data (including NMR spectra), and additional supporting results referenced throughout the manuscript. See DOI: https://doi.org/10.1039/d5ob00888c

Acknowledgements

This work was financially supported by the National Natural Science Foundation of China (No. 21804066), the Shandong Provincial Natural Science Foundation (No. ZR2017BB065, ZR2020QB038 and ZR2024MB041), and the College Students’ Innovation and Entrepreneurship Training Program by Linyi University (No. X202410452251).

References

  1. (a) M. Inoue, Y. Sumii and N. Shibata, ACS Omega, 2020, 5, 10633–10640 CrossRef PubMed; (b) N. A. Meanwell, J. Med. Chem., 2018, 61, 5822–5880 CrossRef PubMed; (c) M. Hird, Chem. Soc. Rev., 2007, 36, 2070–2095 RSC; (d) J. P. Sorrentino and R. A. Altman, ACS Med. Chem. Lett., 2022, 13, 707–713 CrossRef PubMed.
  2. (a) O. A. Tomashenko and V. V. Grushin, Chem. Rev., 2011, 111, 4475–4521 CrossRef; (b) T. Furuya, A. S. Kamlet and T. Ritter, Nature, 2011, 473, 470–477 CrossRef; (c) T. Liang, C. N. Neumann and T. Ritter, Angew. Chem., Int. Ed., 2013, 52, 8214–8264 CrossRef; (d) H. Xiao, Z. Zhang, Y. Fang, L. Zhu and C. Li, Chem. Soc. Rev., 2021, 50, 6308–6319 RSC.
  3. (a) Y. Macé and E. Magnier, Eur. J. Org. Chem., 2012, 2479–2494 CrossRef; (b) T. Chatterjee, N. Iqbal, Y. You and E. J. Cho, Acc. Chem. Res., 2016, 49, 2284–2294 CrossRef PubMed; (c) Y. Wang, J. Wang, G. X. Li, G. He and G. Chen, Org. Lett., 2017, 19, 1442–1445 CrossRef PubMed; (d) S. Barata-Vallejo, M. V. Cooke and A. Postigo, ACS Catal., 2018, 8, 7287–7307 CrossRef; (e) D. E. Yerien, B. Lantaño, S. Barata-Vallejo and A. Postigo, ChemCatChem, 2021, 13, 4497–4506 CrossRef; (f) H. Baguia and G. Evano, Chem. – Eur. J., 2022, 28, e202200975 CrossRef PubMed; (g) Y. Yamamotoa, Adv. Synth. Catal., 2023, 365, 3572–3585 CrossRef; (h) Y. Wang, Z. Cao, Q. He, X. Huang, J. Liu, H. Neumann, G. Chen and M. Beller, Chem. Sci., 2023, 14, 1732–1741 RSC.
  4. (a) A. Studer, Angew. Chem., Int. Ed., 2012, 51, 8950–8958 CrossRef PubMed; (b) S. Kawamura, P. Barrio, S. Fustero, J. Escorihuela, J. Han, V. A. Soloshonok and M. Sodeoka, Adv. Synth. Catal., 2023, 365, 398–462 CrossRef; (c) D. E. Yerien, S. Barata-Vallejo and A. Postigo, ACS Catal., 2023, 13, 7756–7794 CrossRef CAS; (d) K. Tagami and T. Yajima, Chem. Rec., 2023, 23, e202300037 CrossRef CAS.
  5. (a) P. G. Janson, I. Ghoneim, N. O. Ilchenko and K. J. Szabó, Org. Lett., 2012, 14, 2882–2885 CrossRef CAS; (b) X.-Y. Jiang and F.-L. Qing, Angew. Chem., Int. Ed., 2013, 52, 14177–14180 CrossRef CAS PubMed; (c) Y. Yasu, T. Koike and M. Akita, Org. Lett., 2013, 15, 2136–2139 CrossRef CAS PubMed; (d) F. Wang, X. Qi, Z. Liang, P. Chen and G. Liu, Angew. Chem., Int. Ed., 2014, 53, 1881–1886 CrossRef CAS; (e) Y. R. Choi, S. Kang, J. Hwang, H. An and K. B. Hong, ACS Omega, 2024, 9, 47500–47505 CrossRef CAS; (f) H. He, J.-X. Yan, J.-X. Zhu, S.-J. Liu, X.-Q. Liu, P. Chen, X. Wang and Z.-J. Jia, Angew. Chem., Int. Ed., 2025, 64, e202423507 CrossRef CAS.
  6. X. Wang, J. Lei, Y. Liu, Y. Ye, J. Li and K. Sun, Org. Chem. Front., 2021, 8, 2079–2109 RSC.
  7. (a) R. Zhu and S. L. Buchwald, J. Am. Chem. Soc., 2012, 134, 12462–12465 CrossRef CAS PubMed; (b) R. Zhu and S. L. Buchwald, Angew. Chem., Int. Ed., 2013, 52, 12655–12658 CrossRef CAS; (c) J.-S. Lin, X.-Y. Dong, T.-T. Li, N.-C. Jiang, B. Tan and X.-Y. Liu, J. Am. Chem. Soc., 2016, 138, 9357–9360 CrossRef CAS; (d) J.-S. Lin, F.-L. Wang, X.-Y. Dong, W.-W. He, Y. Yuan, S. Chen and X.-Y. Liu, Nat. Commun., 2017, 8, 14841 CrossRef PubMed; (e) J. Yu, H. Yang and H. Fu, Adv. Synth. Catal., 2014, 356, 3669–3675 CrossRef CAS; (f) Y.-Y. Jiang, G.-Y. Dou, K. Xu and C.-C. Zeng, Org. Chem. Front., 2018, 5, 2573–2577 RSC; (g) S. Zhang, L.-J. Li, J.-J. Zhang, J.-Q. Zhang, M.-Y. Xue and K. Xu, Chem. Sci., 2019, 10, 3181–3185 RSC; (h) Q. Wei, J.-R. Chen, X.-Q. Hu, X.-C. Yang, B. Lu and W.-J. Xiao, Org. Lett., 2015, 17, 4464–4467 CrossRef CAS PubMed; (i) H. Xiang, Q. Zhao, Z. Tang, J. Xiao, P. Xia, C. Wang, C. Yang, X. Chen and H. Yang, Org. Lett., 2017, 19, 146–149 CrossRef CAS; (j) B. Chen, H. He, J. Xu, K. Guo, N. Xu, K. Chen and Y. Zhu, Asian J. Org. Chem., 2021, 10, 2360–2364 CrossRef CAS; (k) H. Mei, Y. Zhang, J. Liu, J. Escorihuela, L. Kiss and J. Han, Adv. Synth. Catal., 2025, 367, e202401225 CrossRef CAS.
  8. (a) T. Liu, J. Liu, J. He, Y. Hong, H. Zhou, Y. L. Liu and S. Tang, Synthesis, 2022, 1919–1938 CAS; (b) F. Lucio-Martínez and W. Chaładaj, Adv. Synth. Catal., 2023, 365, 2092–2125 CrossRef.
  9. (a) F. Wang, Y.-D. Wang, L.-C. Cai, Z.-W. Miao and R.-Y. Chen, Chin. J. Org. Chem., 2008, 28, 1523–1533 CAS; (b) R. Karmakar, P. Pahari and D. Mal, Chem. Rev., 2014, 114, 6213–6284 CrossRef CAS PubMed.
  10. (a) H. Yoshida, H. Fukushima, J. Ohshita and A. Kunai, Angew. Chem., Int. Ed., 2004, 43, 3935–3938 CrossRef CAS; (b) K. M. Allan, C. D. Gilmore and B. M. Stoltz, Angew. Chem., Int. Ed., 2011, 50, 4488–4491 CrossRef CAS; (c) Y. Madich, R. Alvarez and J. M. Aurrecoechea, Eur. J. Org. Chem., 2014, 6263–6271 CrossRef CAS; (d) J.-F. Zhao, X.-H. Duan, H. Yang and L.-N. Guo, J. Org. Chem., 2015, 80, 11149–11155 CrossRef CAS; (e) X. Bantreil, A. Bourderioux, P. Mateo, C. E. Hagerman, M. Selkti, E. Brachet and P. Belmont, Org. Lett., 2016, 18, 4814–4817 CrossRef CAS PubMed; (f) X. Li, P. He, H.-B. Zhou and C. Dong, Org. Biomol. Chem., 2018, 16, 2150–2155 RSC; (g) H. Wei, Z. Zhang, X. Zhang, S. Gao, T. Wang, M. Zhao, P. Wei and M. Wang, Org. Biomol. Chem., 2022, 20, 8912–8916 RSC; (h) L. Sun, J. Cui, S. Nie, L. Xie, Y. Wang and L. Wu, Eur. J. Org. Chem., 2022, e202200505 CrossRef CAS.
  11. (a) H. Yang, X.-H. Duan, J.-F. Zhao and L.-N. Guo, Org. Lett., 2015, 17, 1998–2001 CrossRef CAS; (b) F. Lu, J. Xu, H. Li, K. Wang, D. Ouyang, L. Sun, M. Huang, J. Jiang, J. Hu, H. Alhumade, L. Lu and A. Lei, Green Chem., 2021, 23, 7982–7986 RSC; (c) H. Li, F. Lu, J. Xu, J. Hu, H. Alhumade, L. Lu and A. Lei, Org. Chem. Front., 2022, 9, 2786–2791 RSC; (d) C. Pan, S. Luo, Y. Wu, J.-T. Yu and C. Zhu, Org. Chem. Front., 2023, 10, 3479–3484 RSC.
  12. Z.-C. Liu, Q.-Q. Zhao, J. Chen, Q. Tang, J.-R. Chen and W.-J. Xiao, Adv. Synth. Catal., 2018, 360, 2087–2092 CrossRef CAS.
  13. S. Gao, Q. Zhou, Z. Liu, S. Xie, D. Yang, K. Zhang and Z. Zhang, RSC Adv., 2025, 15, 3273–3277 RSC.
  14. (a) C. G. S. Lima, T. de M. Lima, M. Duarte, I. D. Jurberg and M. W. Paixão, ACS Catal., 2016, 6, 1389–1407 CrossRef CAS; (b) G. E. M. Crisenza, D. Mazzarella and P. Melchiorre, J. Am. Chem. Soc., 2020, 142, 5461–5476 CrossRef CAS; (c) Y. Yuan, S. Majumder, M. Yang and S. Guo, Tetrahedron Lett., 2020, 61, 151506 CrossRef CAS; (d) J. D. Lasso, D. J. Castillo-Pazos, J. M. Salgado, C. Ruchlin, L. Lefebvre, D. Farajat, D. F. Perepichka and C.-J. Li, J. Am. Chem. Soc., 2024, 146, 2583–2592 CrossRef CAS; (e) X.-L. Huang, D.-L. Zhang, Q. Li, Z.-B. Xie, Z.-G. Le and Z.-Q. Zhu, Org. Lett., 2024, 26, 3727–3732 CrossRef CAS PubMed; (f) D.-L. Zhang, Z.-G. Le, Q. Li, Z.-B. Xie, W.-W. Yang and Z.-Q. Zhu, Chem. Commun., 2024, 60, 2958–2961 RSC; Z.-Q. Zhu, W.-Y. Zhang, X.-L. Huang, Q. Li, Z.-Z. Xu and H.-Y. Rao, J. Org. Chem., 2025, 90, 2842–2847 Search PubMed.
  15. (a) A. Postigo, Eur. J. Org. Chem., 2018, 6391–6404 CrossRef CAS; (b) D. E. Yerien, S. Barata-Vallejo and A. Postigo, ChemPhotoChem, 2024, 8, e202400112 CrossRef CAS.
  16. (a) F. L. Zeng, K. Sun, X. L. Chen, X. Y. Yuan, S. Q. He, Y. Liu, Y. Y. Peng, L. B. Qu, Q. Y. Lv and B. Yu, Adv. Synth. Catal., 2019, 361, 5176–5181 CrossRef CAS; (b) Y. Liu, X.-L. Chen, K. Sun, X.-Y. Li, F.-L. Zeng, X.-C. Liu, L.-B. Qu, Y.-F. Zhao and B. Yu, Org. Lett., 2019, 21, 4019–4024 CrossRef CAS PubMed; (c) J. Huang, D. Wu, X. Bai, P. Cai and W.-G. Zhu, New J. Chem., 2021, 45, 4925–4929 RSC; (d) I. E. Romero, S. Barata-Vallejo, S. M. Bonesi and A. Postigo, Chem. – Eur. J., 2024, 30, e202400905 CrossRef CAS PubMed; (e) I. E. Romero, M. M. Vallejos, S. Barata-Vallejo, S. M. Bonesi and A. Postigo, Chem. – Eur. J., 2025, 31, e202500133 CrossRef CAS PubMed.
  17. F. Meng, Y. Cui, W. Xu and W.-C. Yang, Org. Lett., 2024, 26, 6884–6888 CrossRef CAS PubMed.

Footnote

These authors contributed equally.

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.